The Methanol Extract ofAngelica sinensisInduces Cell Apoptosis and Suppresses Tumor Growth in Human Malignant Brain Tumors
Author(s) -
Yu-Ling Lin,
Wen-Lin Lai,
HorngJyh Harn,
PeiHsiu Hung,
Ming-Chang Hsieh,
KaiFu Chang,
Xiao-Fan Huang,
KuangWen Liao,
Ming-Shih Lee,
NuMan Tsai
Publication year - 2013
Publication title -
evidence-based complementary and alternative medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.552
H-Index - 90
eISSN - 1741-4288
pISSN - 1741-427X
DOI - 10.1155/2013/394636
Subject(s) - apoptosis , cancer research , in vivo , cell cycle checkpoint , cell cycle , angelica sinensis , cancer , cell growth , brain tumor , u87 , cyclin d1 , medicine , biology , pharmacology , glioma , pathology , traditional chinese medicine , biochemistry , alternative medicine , microbiology and biotechnology
Glioblastoma multiforme (GBM) is a highly vascularized and invasive neoplasm. The methanol extract of Angelica sinensis (AS-M) is commonly used in traditional Chinese medicine to treat several diseases, such as gastric mucosal damage, hepatic injury, menopausal symptoms, and chronic glomerulonephritis. AS-M also displays potency in suppressing the growth of malignant brain tumor cells. The growth suppression of malignant brain tumor cells by AS-M results from cell cycle arrest and apoptosis. AS-M upregulates expression of cyclin kinase inhibitors, including p16, to decrease the phosphorylation of Rb proteins, resulting in arrest at the G 0 -G 1 phase. The expression of the p53 protein is increased by AS-M and correlates with activation of apoptosis-associated proteins. Therefore, the apoptosis of cancer cells induced by AS-M may be triggered through the p53 pathway. In in vivo studies, AS-M not only suppresses the growth of human malignant brain tumors but also significantly prolongs patient survival. In addition, AS-M has potent anticancer effects involving cell cycle arrest, apoptosis, and antiangiogenesis. The in vitro and in vivo anticancer effects of AS-M indicate that this extract warrants further investigation and potential development as a new antibrain tumor agent, providing new hope for the chemotherapy of malignant brain cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom